Introduction
The Oral Anticoagulation Knowledge Test (OAK Test) was specifically designed by Mario M Zeolla, Michael R Brodeur, Angela Dominelli, Stuart T Haines, and Nicole D Allie in 2006 to address a critical healthcare gap. Because oral anticoagulation therapy features narrow therapeutic indices and high risks of severe adverse events, patient education directly impacts survival and medication safety. Consequently, the development of specialized tools to measure patient compliance and comprehension has become paramount. Since its initial publication, this test has gained substantial academic recognition, accumulating over 160 citations in scientific literature. Furthermore, the instrument has consistently demonstrated its reliability and validity across diverse international clinical settings.
This article delves into the OAK Test’s core features, practical clinical applications, and overall validity parameters. Therefore, it aims to provide clinical researchers and authors with actionable insights for enhancing health literacy, optimizing treatment planning, and mitigating bleeding risks in cardiology and hematology environments.
Key Features of the Oral Anticoagulation Knowledge Test (OAK Test)
Purpose and Use
The primary purpose of the OAK Test is to assess patient knowledge regarding oral anticoagulation (warfarin) therapy. Because warfarin demands strict adherence and rigorous monitoring, clinicians and researchers utilize this tool to identify specific knowledge gaps. By identifying these gaps, healthcare teams can design targeted educational interventions, which ultimately improve patient safety and therapeutic outcomes. Consequently, the questionnaire provides crucial insights into how well an individual comprehends the complex demands of their pharmacotherapy regimen.
Target Population
The OAK Test is validated for use with adults aged 18 and older, including the following demographic groups:
- Young adults (18–24 years)
- Middle-aged adults (25–44 years)
- Older adults (45–64 years)
- Seniors (65+ years)
Specifically, it is designed for patient populations actively undergoing oral anticoagulation therapy with warfarin, or individuals preparing to initiate vitamin K antagonist treatment.
Structure
The instrument consists of 20 multiple-choice questions, which capture practical, safety-critical information across five distinct content areas established in the original development study. These key domains include:
- Basic drug information: Core mechanics of the medication, adherence protocols, and management of missed doses.
- Adverse effects: Recognition of bleeding risks and complications related to supratherapeutic dosing.
- Drug–drug interactions: Concomitant use of over-the-counter medications or prescription drugs that alter warfarin efficacy.
- Dietary issues and food interactions: The nutritional impact of vitamin K intake on anticoagulation stability.
- Monitoring and INR-related knowledge: Understanding international normalized ratio (INR) testing and the clinical consequences of subtherapeutic levels.
Through these comprehensive domains, the tool ensures that the most vital safety-related behaviors and indicators are thoroughly evaluated.
Scoring Method
Each correct answer on the 20-item multiple-choice test receives credit, and the total score is calculated as the percentage of correct responses. Therefore, higher percentages directly indicate a greater knowledge of warfarin therapy. While the original development article does not define official, rigid cut-off scores, later independent validation and clinical use studies have categorized performance into three descriptive dimensions:
- Low knowledge: Scores falling below 50%
- Moderate knowledge: Scores ranging from 50% to 75%
- Good knowledge: Scores exceeding 75%
Because these tiers represent study-specific categories, researchers should interpret them dimensionally rather than as absolute clinical cut-offs.
Administration Format
The OAK Test is a versatile instrument that requires no advanced clinical training or specialized expertise to administer. It is highly flexible and can be completed via several modalities:
- Paper-based formats
- Digital or online platforms
- In-person interviews
- Phone or video calls
Because it typically takes only 10 to 15 minutes for patients to complete, this self-administered questionnaire is remarkably practical for busy ambulatory clinics and large-scale, multi-center research studies.
Application of the Oral Anticoagulation Knowledge Test (OAK Test)
The OAK Test has broad, established applications across both clinical operations and scientific research:
- Monitoring: Clinicians can reliably track a patient’s retention of safety protocols over time, allowing for long-term tracking of safety literacy.
- Treatment Planning: Healthcare teams can utilize the test scores to design individualized educational plans and target specific misunderstandings before serious complications occur.
- Research: The test functions as a valuable objective outcome measure in clinical trials and behavioral studies investigating medication adherence, health literacy, and the efficacy of clinical pharmacy interventions.
Languages and availability
To facilitate multicultural research and international collaborations, the OAK Test has been translated and validated in multiple languages, including:
- English
- Portuguese
- Malay
- Turkish
As a proprietary instrument, users must obtain formal permission or licensing before integrating the tool into clinical protocols or funded academic research.
Reliability and Validity
The OAK Test is recognized as a highly reliable and valid instrument for assessing patient treatment literacy. In the original validation study, the English version demonstrated strong construct validity, as patients on warfarin scored significantly higher than age-matched control subjects not taking the medication (72% vs. 52%, p < 0.001). Furthermore, psychometric testing revealed acceptable internal consistency (KR-20 = 0.76) and excellent test–retest reliability (Pearson’s r = 0.81).
International adaptations have similarly confirmed its robust psychometric properties across global cohorts:
- The Malaysian version exhibited an internal consistency alpha of 0.767 and a test–retest reliability of 0.871.
- The Turkish version demonstrated acceptable reliability with a KR-20 value of 0.671.
Validation evidence comes from diverse contexts, including:
- The original validation study link.
- Validation of the Malaysian version Study link.
- Validation of the Turkish version Study link.
- Validation of the Brazilian Portuguese version Study link.
Limitations and Considerations
Despite its strengths, the OAK Test has a few limitations:
- Self-report measure: Because it relies on patient self-reporting, respondents may be influenced by guessing patterns, personal interpretation, or social desirability bias.
- Cultural Bias: Potential variations in regional dietary habits and healthcare infrastructure may alter how certain food and drug interaction items are interpreted across diverse global populations.
- Limited Validation Studies: Compared to more generalized medical tools, this instrument features a relatively limited number of peer-reviewed validation studies, though robust international adaptations do exist.
- Narrow Focus (Limited Domains Covered): The questionnaire is explicitly optimized for warfarin therapy alone; consequently, it lacks validation for tracking patients on DOAC regimens and does not capture broader behavioral or emotional barriers to medication adherence.
Other Versions And Related Questionnaires
While the original 20-item OAK Test remains a cornerstone for assessing vitamin K antagonist therapy, researchers must note its specific clinical scope. It is heavily focused on warfarin and cannot serve as a general knowledge test for direct oral anticoagulants (DOACs). To evaluate newer therapies, investigators can utilize alternative tools such as the Anticoagulation Knowledge Tool (AKT), which spans both vitamin K antagonists and DOACs.
Additionally, depending on the research objectives, the OAK Test can be cross-referenced or deployed alongside complementary instruments, including:
- AKA: Anticoagulation Knowledge Assessment.
- AKT: Anticoagulation Knowledge Tool.
- C-OAKT: Chinese Oral Anticoagulants Knowledge Tool.
Additional Resources
- The Original Validation. Study link.
- You can access the questionnaire as a PDF through this link (Note: The original external ACP link hosted in the development paper is currently inactive).
- For inquiries, contact Mario M. Zeolla, the first author of the questionnaire at zeollam@acp.edu
Frequently Asked Questions (FAQ)
- Who can use the OAK Test?
Clinicians, researchers, and healthcare providers use the OAK Test for patients aged 18 and older who are prescribed warfarin therapy. - How long does it take to complete the OAK Test?
Patients typically take 10 to 15 minutes to complete the OAK Test, which makes it highly feasible for use in clinical and research settings. - How is the OAK Test administered?
Healthcare teams can administer the questionnaire via paper, digital, or interview formats—offering excellent flexibility in usage. - Is there any cost to using the OAK Test?
The OAK Test is proprietary and requires permission from the authors or publishers. For commercial or funded academic projects, formal licensing may be necessary.
- Who can use the OAK Test?
A Word from ResRef about the Oral Anticoagulation Knowledge Test (OAK Test)
The Oral Anticoagulation Knowledge Test (OAK Test) is a brief and practical instrument developed to assess patients’ knowledge of warfarin therapy. It can help identify knowledge gaps related to INR monitoring, adherence, drug and food interactions, and bleeding risk, supporting targeted patient education and research on anticoagulation safety. It should be interpreted as a warfarin-focused tool rather than a general knowledge test for all oral anticoagulants.
References
- Zeolla MM, Brodeur MR, Dominelli A, Haines ST, Allie ND. Development and Validation of an Instrument to Determine Patient Knowledge: The Oral Anticoagulation Knowledge Test. Annals of Pharmacotherapy. 2006;40(4):633-638. Link.
- Laila Mahmoud Matalaqah, Khaldoon Radaideh, Syed Azhar Syed Sulaiman, Mohamed Azmi Hassali, Muhamad Ali Sk Abdul Kader. An instrument to measure anticoagulation knowledge among Malaysian community: A translation and validation study of the Oral Anticoagulation Knowledge (OAK) Test. Asian Journal of Biomedical and Pharmaceutical Sciences, 2013, 3: (20), 30-37. Link.
- Türker M, Sancar M, Demirtunç R, Uçar N, Uzman O, Ay P, Kozan Ö, Okuyan B. Validation of a Knowledge Test in Turkish Patients on Warfarin Therapy at an Ambulatory Anticoagulation Clinic. Turk J Pharm Sci. 2021 Sep 1;18(4):445-451. Link.
- Silva de Araujo M, Sanches C, et al. Cross-cultural adaptation and validation of the Oral Anticoagulation Knowledge Test (OAK Test) for Brazilian Portuguese. Ciência & Saúde Coletiva. 2018;23(11):3811-3820. Link.
